Deep Tech Startups
5,913 companies tagged Deep Tech, with their investors and founders.
Synplogen is a synthetic biology startup spun out of Kobe University that offers custom artificial gene synthesis and DNA library construction services using its proprietary OGAB and Combinatorial-OGAB (Combi-OGAB) DNA assembly methods. It also operates a gene-therapy biofoundry that designs, develops, and analyzes gene-therapy products such as viral vectors, including CMC development work.
2 investors
Synteris develops advanced ceramic materials using its proprietary SLRS process, with applications including DoD/DARPA hypersonic flight programs. The company focuses on non-oxide ceramics and the commercialization of early-stage materials science innovations.
2 investors
SynthLabs develops reinforcement learning methods for large reasoning models, such as Adaptive Length Penalty (ALP), which adjusts generation length to problem difficulty to reduce token usage. Its work targets AI research and the development of more efficient reasoning models.
2 investors
Synthefy develops Nori, an open-weight foundation model for tabular prediction that returns predictions from labeled context without fitting or training a new model. The model is offered as open source under Apache 2.0 and via a managed hosted API, positioned as an alternative to tools like XGBoost.
2 investors
Syntonym provides real-time anonymization software for machine vision that removes personal identifiers from faces and license plates, using generative AI to replace them with synthetic versions while preserving data utility for AI training and analytics. It also offers automatic blurring, and serves customers in automotive/mobility, robotics, smart devices, and vision-language model development via cloud API, on-premise, and edge SDK deployments.
2 investors
Tacit develops RNA repair technology called Splicing-Directed Repair, which uses naturally-occurring biological systems to fix genetic mutations as an alternative to conventional gene editing. The company aims to build a platform for treating a range of genetic diseases.
2 investors
Taconic Biosciences provides genetically engineered mouse and rat models, humanized immune system mice, custom model generation, colony management, and in vivo research services. It serves drug discovery and preclinical researchers, offering integrated laboratory animal models and services from model selection through study-ready cohorts.
2 investors
TagoreTech is a fabless semiconductor company developing GaN and GaAs RF and power management products, including GaN-on-Silicon devices, for applications such as military and public safety communications, radar, drones, jammers, and 5G cellular infrastructure. It operates design centers in Arlington Heights, Illinois and Arizona in the USA, and in Kolkata, India.
2 investors
Tamarind provides a computational platform for protein and molecular engineering, offering AI and physics-based tools to design antibodies, peptides, enzymes, and small molecules. The platform integrates state-of-the-art published tools like AlphaFold and RFdiffusion through a user-friendly interface for life sciences companies.
2 investors
Valo builds an AI-driven drug discovery and development platform that combines real-world human data, causal inference, statistical genetics, and predictive chemistry to identify disease targets and engineer small-molecule compounds. It applies closed-loop modeling and laboratory capabilities to advance lead compounds into drug candidates.
2 investors
TAU Systems is developing an X-ray laser light source built on compact particle accelerators, intended as the next-generation light source for semiconductor lithography machines. Its technology aims to fit inside existing chip fabs and print smaller chip features than current lithography light sources allow.
2 investors
TCN Prime develops medical devices for cardiovascular applications, including innovative catheter systems for treating aortic stenosis and ECMO support. The company serves healthcare providers and patients in the cardiovascular intervention space.
2 investors
Teitur Trophics is a biotech company developing first-in-class cyclic peptides that target lysosomal, mitochondrial and pro-survival signaling pathways to preserve neuronal function. Its lead candidate, TT-P34, is a subcutaneous peptide in Phase I clinical development as a disease-modifying therapy for neurodegenerative diseases including Parkinson's, Huntington's disease and frontotemporal dementia.
2 investors
Tejas Networks, part of the Tata Group, designs and manufactures telecommunications equipment for building end-to-end networks, including 4G/5G wireless, fiber broadband, optical transport, packet switching, Satellite IoT, and broadcast and network-management solutions. It serves telecom operators, service providers, utilities, and government organizations in over 75 countries.
2 investors
Terasi develops pocket-sized mm-wave radios that provide gigabit-speed, physically secure wireless data links resistant to jamming and interception. The hardware targets critical sectors such as defense networks, industrial systems, and emergency response, with in-house RF design, microelectronics, manufacturing, and testing based in Stockholm.
2 investors
Terecircuits develops materials, polymers, and lithography-based processes for micron-scale assembly and packaging in advanced manufacturing, enabling components smaller than a grain of pollen to be assembled at scale. Its technology targets makers of IoT devices, wearables, augmented/virtual reality, autonomous vehicles, and medical devices.
2 investors
Ternary Therapeutics designs small molecule drugs called molecular glues using AI and physics-based modeling to enable protein interactions for treating diseases including cancer and arthritis. The company applies machine learning to structure-based drug discovery, addressing the geometric constraints of rational drug design.
2 investors
TERRA Labo (ζ ͺεΌδΌη€Ύγγ©γ©γ) develops long-range unmanned aerial vehicles and an aerial measurement and analysis platform ("Terra Geo Scan System") for disaster response and monitoring. The Japanese company applies its drone technology to disaster management and dual-use defense/security applications, including collaborations with public agencies.
2 investors
TerraFixing is a climate infrastructure company building modular Direct Air Capture units that capture and purify COβ directly from the atmosphere, designed to operate in cold Far North climates. The high-purity COβ output serves as a localized COβ supply while enabling large-scale carbon removal infrastructure.
2 investors
TerraPower develops advanced nuclear reactors and related technologies to generate carbon-free electricity and heat for industrial decarbonization, while also producing radioisotopes for medical cancer treatments. The company addresses climate change and energy security through innovative nuclear technology.
2 investors
Terray Therapeutics develops small molecule drugs using its EMMI platform, which combines proprietary hardware, custom-generated datasets, and AI models for drug discovery. The company operates in the biotech and pharmaceutical research space.
2 investors
Tesorai builds AI-powered data analysis software for life sciences researchers to extract insights from complex experimental datasets. The platform serves academic and biotech researchers who need to identify patterns and extract meaningful signals from massive datasets generated by high-throughput assays and other experiments.
2 investors
Tesseract designs and manufactures spacecraft propulsion hardware, including off-the-shelf thrusters, multi-thruster modules, and complete propulsion systems for space missions. The company prioritizes low-toxicity green propellants, cost-effective manufacturing, and flight-qualified reliability for aerospace applications.
2 investors
Thaleron develops a mechanical energy storage solution designed to reduce costs and accelerate the transition to renewable energy systems.
2 investors